Clinical Trials
147
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (144 trials with phase data)• Click on a phase to view related trials
Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol
- Conditions
- Acute Coronary Syndrome
- Interventions
- Drug: Xuesaitong soft capsule (main ingredient is Panax notoginseng saponins)Drug: placebo capsule
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-25
- Target Recruit Count
- 400
- Registration Number
- NCT06845254
- Locations
- 🇨🇳
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
- Conditions
- Diarrhea-predominant Irritable Bowel Syndrome
- Interventions
- Drug: Tong-Xie-Yao-Fang
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2024-12-17
- Target Recruit Count
- 60
- Registration Number
- NCT06737666
- Locations
- 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, China
Clinical Study and Molecular Mechanism of Xuesaitong Soft Capsule in the Treatment of Acute Coronary Syndrome
- Conditions
- Acute Coronary Syndrome
- Interventions
- Drug: Xuesaitong soft capsule (main ingredient is Panax notoginseng saponins)
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Target Recruit Count
- 50
- Registration Number
- NCT06618495
- Locations
- 🇨🇳
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China, Beijing, Beijing, China
Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne
- Conditions
- AcnePhotodynamic Therapy
- Interventions
- Drug: N-chlorin e6 triglumineProcedure: acne removal surgery
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2024-03-15
- Target Recruit Count
- 46
- Registration Number
- NCT06311890
- Locations
- 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Sciences Organization, Beijing, China
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
- Conditions
- Hypertension,Essential
- Interventions
- Drug: Songling Xuemaikang CapsulesBehavioral: Lifestyle interventionDrug: Placebo
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-08-20
- Target Recruit Count
- 100
- Registration Number
- NCT06093932
- Locations
- 🇨🇳
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing, China
🇨🇳Suzhou Hosptial of Traditional Chinese Medicine, Suzhou, Jiangsu, China
🇨🇳Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next